Table 2

Characteristics of respondents using desferrioxamine

31. Characteristics

Respondents using desferrioxamine (N = 1573)


Age N (%)

<10

329 (21.5)

10–18

464 (30.3)

>18

739 (48.2)

Male N (%)

765 (49.0)

Receiving blood transfusions N (%)

1564 (99.6)

Complications N (%)

Heart disease

154 (11.2)

Liver disease

258 (18.8)

Diabetes

133 (9.7)

Thyroid problem

85 (6.3)

32. Mean age at diagnosis, months (SD)

19.1 (28.4)


Ward et al. BMC Clinical Pharmacology 2002 2:3   doi:10.1186/1472-6904-2-3

Open Data